Similarly, loss or reduced expression of molecules such as FAK have previously been associated with a less aggressive cancer type and inhibition/disruption of this pathway as a potential therapeutic [40], rather than a more aggressive cellular phenotype reported here. The gene discussed is PTK2; the disease is cancer.